Complete remission after the first cycle of induction chemotherapy determines the clinical efficacy of relapse-preventive immunotherapy in acute myeloid leukaemia
Other text in scientific journal, 2020
No abstract available
aml
immunotherapy
IL-2
histamine dihydrochloride
chemotherapy
Author
Malin S. Nilsson
University of Gothenburg
Alexander Hallner
University of Gothenburg
Mats Brune
University of Gothenburg
Staffan Nilsson
Chalmers, Mathematical Sciences, Applied Mathematics and Statistics
University of Gothenburg
Fredrik B. Thoren
University of Gothenburg
Anna Martner
University of Gothenburg
Kristoffer Hellstrand
University of Gothenburg
British Journal of Haematology
0007-1048 (ISSN) 1365-2141 (eISSN)
Vol. 188 4 e49-e53Subject Categories
Pediatrics
Hematology
Cancer and Oncology
DOI
10.1111/bjh.16320